Keywords: سرطان پروستات; Urinary tract; Urothelial carcinoma; Ureter; Renal pelvis; Bladder neoplasm; Prognostic; Recurrence; Survival;
مقالات ISI سرطان پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان پروستات; Bladder cancer; Urothelial carcinoma; Signaling pathways; Tumorigenesis; Treatment; Targeted therapies
Keywords: سرطان پروستات; Bladder cancer; Urothelial carcinoma; Mutations; Somatic copy number alterations; Cell cycle; Epigenetics; Molecular subtypes;
Keywords: سرطان پروستات; Urothelial carcinoma; Biologic agents; Therapeutic targets; Systemic therapy;
Keywords: سرطان پروستات; Urothelial carcinoma; Variant histology; Micropapillary bladder cancer; Radical cystectomy; Chemotherapy; Treatment guidelines;
Keywords: سرطان پروستات; Upper tract urothelial carcinoma; Kidney neoplasms; Ureteral neoplasms; Urothelial carcinoma; Nephroureterectomy; Chemotherapy; Radiotherapy;
Keywords: سرطان پروستات; Geriatric oncology; Urothelial carcinoma; Bladder cancer; Renal cell carcinoma; Kidney cancer; Prostate cancer; Systemic therapy; Geriatric assessment tools;
Keywords: سرطان پروستات; Urothelial carcinoma; Bladder cancer; Biomarkers; Immunotherapy; Targeted therapy;
Keywords: سرطان پروستات; Fascin; Immunoreactivity scores; Urothelial carcinoma
Keywords: سرطان پروستات; carcinoma; transitional cell; endoscopy; CT; computerized tomography; RNU; radical nephroureterectomy; UC; urothelial carcinoma; UTUC; upper tract urothelial carcinoma;
Keywords: سرطان پروستات; Urine history; Gross examination; Matula; Urine cytology; Urothelial carcinoma; Tumor markers
Keywords: سرطان پروستات; Bladder cancer; Urinary bladder; Urothelial carcinoma; Young adults
Keywords: سرطان پروستات; urinary bladder; urothelium; carcinoma; lymph nodes; neoplasm metastasis; CT; computerized tomography; LN; lymph node; LND; LN dissection; OS; overall survival; UC; urothelial carcinoma;
Keywords: سرطان پروستات; Smoking; Urothelial carcinoma; Bladder; Smoking cessation;
Keywords: سرطان پروستات; Urothelial carcinoma; Locally advanced disease; Perioperative chemotherapy; Clavien complications; Renal-function changes;
Keywords: سرطان پروستات; Thromboembolism; Urothelial carcinoma; Neoadjuvant chemotherapy
Keywords: سرطان پروستات; invasive bladder cancer; radical cystectomy; radiotherapy; survival; transurethral resection; urothelial carcinoma
Keywords: سرطان پروستات; Distant metastasis; Local recurrence; Radical cystectomy; Survival; Urothelial carcinoma
Keywords: سرطان پروستات; Chinese population; chronic kidney disease; upper urinary tract carcinoma; urothelial carcinoma
Keywords: سرطان پروستات; Urothelial carcinoma; Upper urinary tract; Ureter; Survival; Recurrence; Ureterectomy;
Keywords: سرطان پروستات; Upper urinary tract; Urothelial carcinoma; Bladder cancer; Recurrence; Survival; Prognostic factor;
Keywords: سرطان پروستات; Urothelial carcinoma; Bladder cancer; Molecular marker; Biomarker; Urine; Detection; Surveillance
Keywords: سرطان پروستات; Urothelial carcinoma; Ureteral cancer; Renal pelvis cancer; Epidemiology; Carcinogens; Biomarkers
Keywords: سرطان پروستات; Urinary bladder; Urothelial carcinoma; Grading; Reproducibility; Prognostic value
Keywords: سرطان پروستات; Urothelial carcinoma; Urine cytology; Atypical urothelial cells; Bladder cancer; Urinary bladder neoplasm; Urinary bladder pathology;
Keywords: سرطان پروستات; Urothelial carcinoma; Urinary cytology; The Paris System for Reporting Urinary Cytopathology; The Johns Hopkins System for Reporting Urinary Cytopathology; Interobserver reproducibility
Keywords: سرطان پروستات; Bladder cancer; Urothelial carcinoma; Transfusion; Outcomes; Intraoperative blood transfusion;
Keywords: سرطان پروستات; Urothelial carcinoma; Upper urinary tract; Comorbidity; Survival;
Keywords: سرطان پروستات; Telomere; PUNLMP; Urothelial carcinoma; Q-FISH; Chromosomal instability; Anaphase bridge; Karyotype analysis
Keywords: سرطان پروستات; FISH; Urothelial carcinoma; Cytology; Molecular
Keywords: سرطان پروستات; Urothelial carcinoma; Bladder cancer; Molecular marker; Prediction; Prognosis; Survival; Biomarker; Tissue-based; Blood-based
Keywords: سرطان پروستات; Smoking; Urothelial carcinoma; Prognosis; Outcomes; Recurrence; Progression; Survival
Keywords: سرطان پروستات; Bladder tumor; Meta-analysis; Nephroureterectomy; Risk factors; Upper urinary tract; Urothelial carcinoma
Keywords: سرطان پروستات; Urinary bladder; Urothelial carcinoma; Biomarkers; Prognosis; Tumorigenesis;
Keywords: سرطان پروستات; Arsenic; Urothelial carcinoma; Lung cancer; Lifetime risk; Cigarette smoking;
Keywords: سرطان پروستات; Bladder cancer; Radical cystectomy; Urothelial carcinoma; Histology; Variant histology; Survival; Prognosis;
Keywords: سرطان پروستات; Upper urinary tract; Ureter; Renal pelvis; Urothelial carcinoma; Lymphovascular invasion; Prognosis; Meta-analysis;
Keywords: سرطان پروستات; Voided urine cytology; liquid-based cytology; Histology; Urothelial carcinoma; TERT gene mutation analysis
Keywords: سرطان پروستات; Urothelial carcinoma; Upper urinary tract; Laparoscopic nephroureterectomy
Urothelial neoplasms in pediatric and young adult patients: A large single-center series
Keywords: سرطان پروستات; Urothelial neoplasms; Urothelial carcinoma; Bladder neoplasia; Pediatric; Adolescent;
Pourquoi l'urologue doit s'intéresser à l'immunothérapie, quelles sont les indications établies en 2018 et celles en perspectives ?
Keywords: سرطان پروستات; Cancer de prostate; Cancer du rein; Cancer de vessie; Carcinome urothélial; Immunothérapie; Prostate cancer; Kidney cancer; Bladder cancer; Urothelial carcinoma; Immunotherapy;
FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients
Keywords: سرطان پروستات; Clinical response; Pathologic stage; Urinary bladder neoplasms; Urothelial carcinoma;
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial
Keywords: سرطان پروستات; Bladder cancer; Urothelial carcinoma; Biomarkers; Neoadjuvant chemotherapy; Gemcitabine; Cisplatin;
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study
Keywords: سرطان پروستات; Bladder cancer; Urothelial carcinoma; Neoadjuvant therapy; Sorafenib; Chemotherapy;
Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy
Keywords: سرطان پروستات; Bladder cancer; Urothelial carcinoma; Myeloid-derived suppressor cells; MDSC; Tumor immunology; Biomarkers;
Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial
Keywords: سرطان پروستات; Bladder cancer; Chemotherapy; Nephro-ureterectomy; Upper urinary tract; Urothelial carcinoma;
Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer
Keywords: سرطان پروستات; Key words; microRNAs; miR-187-5p; Bladder cancer; Urothelial carcinoma; Recurrence;
Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study
Keywords: سرطان پروستات; DNA methylation; Noninvasive detection; Transitional cell carcinoma; Urinary biomarkers; Urothelial carcinoma;
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer
Keywords: سرطان پروستات; Non-muscle invasive; Bladder cancer; Recurrence and progression; Conditional analysis; Urothelial carcinoma;
SATB1 and bladder cancer: Is there a functional link?
Keywords: سرطان پروستات; Urothelial carcinoma; Chemoresistance; Cisplatin; Oncomine; Laser-capture microdissection; Apoptosis;